Key result
Mitral valve repair for degenerative MR with LVSD achieves ~97% eight-year survival.
Why the study?
To evaluate the early and mid-term outcomes of mitral valve repair for degenerative mitral regurgitation in patients with left ventricular systolic dysfunction.
Does mitral valve repair provide safe early and mid-term outcomes in patients with degenerative mitral regurgitation and left ventricular systolic dysfunction?
Cohort (n=322)
No
Does mitral valve repair provide safe early and mid-term outcomes in patients with degenerative mitral regurgitation and left ventricular systolic dysfunction?
Mitral valve repair can be safely performed in patients with degenerative mitral regurgitation and left ventricular systolic dysfunction, yielding excellent mid-term survival, though older age and worse baseline LV parameters predict postoperative LV deterioration.
Answers are grounded in this paper and cite their sources.
Supports safe mitral valve repair in this population; leaves open need for randomized confirmation before changing practice.
BACKGROUND: This study aims to evaluate the early and mid-term outcomes of mitral valve repair for degenerative mitral regurgitation (MR) in patients with left ventricular systolic dysfunction. METHODS: From January 2005 to December 2016, the profiles of patients with degenerative MR who underwent mitral valve repair at our institution were analyzed. Left ventricular systolic dysfunction was defined as an ejection fraction < 60% or left ventricular end-systolic dimension > 40 mm. Finally, 322 patients with left ventricular systolic dysfunction were included in this study. The prognosis of left ventricular function during follow-up was evaluated and preoperative factors associated with deteriorated left ventricular systolic function during follow-up were analyzed. RESULTS: The in-hospital mortality rate was 1.6%. The rate of eight-year overall survival, freedom from reoperation for mitral valve and freedom from recurrent MR were 96.9, 91.2 and 73.4%, respectively. Intraoperative residual mild MR (hazard ratio 4.82) and an isolated anterior leaflet lesion (hazard ratio 2.48) were independent predictive factors for recurrent MR. During follow-up, 212 patients underwent echocardiography examinations at our institution. Among them, 132 patients had improved left ventricular systolic function, and 80 patients had deteriorated left ventricular systolic. Freedom from recurrent MR was found in 75.9% of the improved left ventricular systolic function group and 56.2% of the deteriorated left ventricular systolic function group (P = 0.047). An age > 50 years (odds ratio 2.40), ejection fraction≤52% (odds ratio 2.79) and left ventricular end-systolic dimension≥45 mm (odds ratio 2.31) were independent risk factors for deteriorated left ventricular systolic function during follow-up. CONCLUSIONS: Mitral valve repair could be safely performed for degenerative MR in patients with left ventricular systolic dysfunction. Intraoperative residual mild MR and an isolated anterior leaflet lesion were independent predictive factors for recurrent MR. An age > 50 years, ejection fraction≤52% and left ventricular end-systolic dimension≥45 mm were independent risk factors for deteriorated left ventricular systolic function during follow-up.
No takes yet. Share an insight, caveat, or question.
Li et al. (2020) conducted a cohort in Degenerative mitral regurgitation with left ventricular systolic dysfunction (n=322). Mitral valve repair was evaluated on Eight-year overall survival. Mitral valve repair for degenerative mitral regurgitation in patients with left ventricular systolic dysfunction achieved an eight-year overall survival rate of 96.9%.
Synapse has enriched 10 related papers. Consider them for comparative context: